• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于整数的风险评分模型预测肝细胞癌患者肝切除术后 90 天死亡率。

Development of an Integer-based Risk Score to Predict 90-Day Mortality After Hepatectomy in Patients With Hepatocellular Carcinoma.

机构信息

Departments of Epidemiology.

Biostatistics.

出版信息

Am J Clin Oncol. 2020 Sep;43(9):640-647. doi: 10.1097/COC.0000000000000724.

DOI:10.1097/COC.0000000000000724
PMID:32889834
Abstract

BACKGROUND

The incidence of liver cancer has more than tripled since 1980. Hepatectomy represents the major curative treatment for liver cancer. The risk factors associated with 90-day mortality after hepatectomy are not well understood and there are currently no good prediction models for this outcome. The objectives of the current study were to identify risk factors of 90-day mortality after hepatectomy in patients with hepatocellular carcinoma and to develop an integer-based risk score using the National Cancer Database.

METHODS

Hepatectomies recorded in the National Cancer Database during 2004-2012 were reviewed for 90-day mortality. Risk factors were identified by multivariate logistic regression models. An integer-based risk score was developed using the β coefficients derived from the logistic regression model and tested for discriminatory ability. According to the total risk score, patients were grouped into 4 risk groups.

RESULTS

The overall 90-day mortality was 10.2%. Ten risk factors were identified, which included sex, age, race/ethnicity, insurance status, education, annual hospital volume, stage, tumor grade, Charlson-Deyo Score, and surgical procedure. The risk of 90-day mortality was stratified into 4 groups. The calculated 90-day mortality rates were 2.47%, 5.88%, 12.58%, and 24.67% for low-risk, medium-risk, high-risk, and excessive-risk groups, respectively. An area under the receiver operating characteristic curve of 0.69 was obtained for model discrimination.

CONCLUSIONS

The integer-based risk score we developed could easily quantify each patient's risk level and predict 90-day mortality after hepatectomy. The stratified risk score could be a useful addition to perioperative risk management and a tool to improve 90-day mortality after hepatectomy.

摘要

背景

自 1980 年以来,肝癌的发病率增长了两倍多。肝切除术是肝癌的主要治疗方法。肝切除术后 90 天死亡率的相关危险因素尚不清楚,目前尚无针对该结果的良好预测模型。本研究的目的是确定肝细胞癌患者肝切除术后 90 天死亡率的危险因素,并使用国家癌症数据库开发基于整数的风险评分。

方法

回顾了 2004 年至 2012 年期间国家癌症数据库中记录的肝切除术,以评估 90 天死亡率。通过多变量逻辑回归模型确定危险因素。使用从逻辑回归模型中得出的β系数开发基于整数的风险评分,并测试其判别能力。根据总风险评分,将患者分为 4 个风险组。

结果

总体 90 天死亡率为 10.2%。确定了 10 个危险因素,包括性别、年龄、种族/民族、保险状况、教育程度、医院年手术量、分期、肿瘤分级、Charlson-Deyo 评分和手术方式。90 天死亡风险分层为 4 组。计算出的低危、中危、高危和高危组的 90 天死亡率分别为 2.47%、5.88%、12.58%和 24.67%。模型判别获得的受试者工作特征曲线下面积为 0.69。

结论

我们开发的基于整数的风险评分可以简单地量化每个患者的风险水平,并预测肝切除术后 90 天的死亡率。分层风险评分可作为围手术期风险管理的有用补充,也是提高肝切除术后 90 天死亡率的工具。

相似文献

1
Development of an Integer-based Risk Score to Predict 90-Day Mortality After Hepatectomy in Patients With Hepatocellular Carcinoma.基于整数的风险评分模型预测肝细胞癌患者肝切除术后 90 天死亡率。
Am J Clin Oncol. 2020 Sep;43(9):640-647. doi: 10.1097/COC.0000000000000724.
2
Development and validation of a predictive score for perioperative transfusion in patients with hepatocellular carcinoma undergoing liver resection.肝细胞癌患者肝切除围手术期输血预测评分的建立与验证
Hepatobiliary Pancreat Dis Int. 2015 Aug;14(4):394-400. doi: 10.1016/s1499-3872(15)60362-9.
3
RAM score is an effective predictor for early mortality and recurrence after hepatectomy for hepatocellular carcinoma.RAM 评分是预测肝癌肝切除术后早期死亡率和复发的有效指标。
BMC Cancer. 2017 Nov 9;17(1):742. doi: 10.1186/s12885-017-3748-9.
4
Different clinical risk scores for prediction of early mortality after liver resection for hepatocellular carcinoma: which is the best?预测肝细胞癌肝切除术后早期死亡率的不同临床风险评分:哪一个是最佳的?
ANZ J Surg. 2019 Oct;89(10):1275-1280. doi: 10.1111/ans.15368. Epub 2019 Aug 6.
5
Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.肝癌患者肝切除术后发生腹腔内感染的肿瘤学预后较差。
World J Gastroenterol. 2015 May 14;21(18):5598-606. doi: 10.3748/wjg.v21.i18.5598.
6
In-hospital mortality from liver resection for hepatocellular carcinoma: a simple risk score.肝癌肝切除术后院内死亡率:一个简单的风险评分。
Cancer. 2010 Apr 1;116(7):1733-8. doi: 10.1002/cncr.24904.
7
Association Between Noninvasive Fibrosis Markers and Postoperative Mortality After Hepatectomy for Hepatocellular Carcinoma.非侵入性纤维化标志物与肝癌肝切除术后术后死亡率的关系。
JAMA Netw Open. 2019 Jan 4;2(1):e187142. doi: 10.1001/jamanetworkopen.2018.7142.
8
Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy.基于大肝切除术新定义的多中心分析:肝癌根治性切除术后长期生存改善。
J Gastrointest Surg. 2013 Jan;17(1):66-77; discussion p.77. doi: 10.1007/s11605-012-2005-4. Epub 2012 Sep 5.
9
[A new prognostic score system of hepatocellular carcinoma following hepatectomy].[一种肝切除术后肝细胞癌的新预后评分系统]
Zhonghua Zhong Liu Za Zhi. 2017 Dec 23;39(12):903-909. doi: 10.3760/cma.j.issn.0253-3766.2017.12.005.
10
Controlling nutritional status (CONUT) score-based nomogram to predict overall survival of patients with HBV-associated hepatocellular carcinoma after curative hepatectomy.基于控制营养状态(CONUT)评分的列线图预测 HBV 相关肝细胞癌患者根治性肝切除术后的总生存。
Clin Transl Oncol. 2020 Mar;22(3):370-380. doi: 10.1007/s12094-019-02137-4. Epub 2019 Jun 14.

引用本文的文献

1
Predictive factors of 90-day mortality after curative hepatic resection for hepatocellular carcinoma: a western single-center observational study.根治性肝切除术后 90 天死亡率的预测因素:一项西方单中心观察性研究。
Langenbecks Arch Surg. 2024 May 3;409(1):149. doi: 10.1007/s00423-024-03337-5.
2
Pharmacokinetics and Disposition of Heparin-Binding Growth Factor Midkine Antisense Oligonucleotide Nanoliposomes in Experimental Animal Species and Prediction of Human Pharmacokinetics Using a Physiologically Based Pharmacokinetic Model.肝素结合生长因子中期因子反义寡核苷酸纳米脂质体在实验动物物种中的药代动力学与处置以及使用基于生理的药代动力学模型预测人体药代动力学
Front Pharmacol. 2021 Nov 3;12:769538. doi: 10.3389/fphar.2021.769538. eCollection 2021.